# clm_86055E0F3919

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_research_and_development  
value: 743,000,000 United States dollar  
valid_from: 2015-09-30  
valid_to: 2016-03-31  
published: 2015-11-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4A46A41D0E94  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly research and development: 743,000,000 United States dollar", as of 2015-09-30 (until 2016-03-31). Claim clm_86055E0F3919, https://asof.is/claim/clm_86055E0F3919, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209515000033/0000882095-15-000033-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2015, filed 2015-11-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209515000033/0000882095-15-000033-index.htm (primary, SEC EDGAR 10-Q Q3 FY2015, published 2015-11-04)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_research_and_development | 818,000,000 United States dollar | valid 2015-06-30 to 2015-09-30 | conf 0.95 | superseded | superseded_by [clm_86055E0F3919](/claim/clm_86055E0F3919.md) | [clm_BD4CAF70327B](/claim/clm_BD4CAF70327B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.